Mannkind (MNKD) Other Non Operating Income (2010 - 2026)
Mannkind (MNKD) reported Other Non Operating Income of $1.3 million for Q1 2026, up 152.53% year-over-year from $521916.4 in Q1 2025, and down 80.45% quarter-over-quarter from $6.7 million in Q4 2025.
Mannkind (MNKD) Other Non Operating Income (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Other Non Operating Income data on file, last reported at $1.3 million in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $1.3 million, up 152.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (up 281900.0% YoY), and the FY2025 annual result was -$1.0 million, down 125.83% from the prior year.
- Other Non Operating Income slipped to $1.3 million in Q1 2026 per MNKD's latest filing, from $6.7 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $6.7 million in Q4 2025 and troughed at -$5.4 million in Q2 2025.
- A 5-year average of $714941.2 and a median of $318000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income surged 1553.77% in 2024, then tumbled 1113.8% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $105000.0 in 2022, then tumbled by 802.86% to -$738000.0 in 2023, then slumped by 344.44% to -$3.3 million in 2024, then soared by 305.58% to $6.7 million in 2025, then sank by 80.45% to $1.3 million in 2026.
- Business Quant data shows MNKD's Other Non Operating Income at $1.3 million in Q1 2026, $6.7 million in Q4 2025, and $120000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Mannkind | 1.13 Bn | 995.19 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | 6.74 Mn |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | -5.36 Mn |
| Mar 31, 2025 | -2.51 Mn |
| Dec 31, 2024 | -3.28 Mn |
| Sep 30, 2024 | 5.26 Mn |
| Jun 30, 2024 | 529,000.00 |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | -738,000.00 |
| Sep 30, 2023 | 318,000.00 |
| Jun 30, 2023 | -143,000.00 |
| Mar 31, 2023 | 111,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 1.80 Mn |
| Jun 30, 2022 | 4.50 Mn |
| Mar 31, 2022 | 1.98 Mn |
| Dec 31, 2021 | -22.20 Mn |
| Sep 30, 2021 | 2.07 Mn |
| Jun 30, 2021 | -903,000.00 |